Timberlyne therapeutics headquarters details
Location map
Open in Google MapsAll Timberlyne therapeutics office locations
| City | State / region | Country | Type |
|---|---|---|---|
| San Diego HQ | California | United States | Headquarters |
About Timberlyne therapeutics
Timberlyne therapeutics (Private) is headquartered in San Diego, California, United States. Founded in 2024, the company operates across 1 countries with approximately 13 employees worldwide.
Where is Timberlyne therapeutics's main office?
Timberlyne therapeutics's main headquarters office is located at San Diego, California, USA, San Diego, California 92134. This serves as the company's primary corporate address and is home to its executive leadership team.
Timberlyne therapeutics regional offices
Beyond its headquarters in San Diego, Timberlyne therapeutics maintains 1 offices across 1 countries. Regional offices span 1 countries.
Timberlyne therapeutics contact information
The main switchboard for Timberlyne therapeutics headquarters can be reached at —. For investor relations, visit timberlyne-tx.com/investor-relations.
What does Timberlyne therapeutics do?
Timberlyne Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of transformational therapies for autoimmune diseases. We are leveraging the extensive drug development expertise of our team to acquire best-in-class assets against compelling targets, and applying them to disease areas with significant unmet need. Timberlyne’s lead program, CM313, is an IgG1 monoclonal antibody with enhanced complement-dependent cytotoxicity that targets CD38. By targeting CD38, highly expressed on plasma cells, NK cells, and other immune cells, CM313 can modulate multiple arms of the immune system leading to both rapid and durable responses across a range of autoimmune diseases. CM313 has been tested in numerous disease states including Immune Thrombocytopenia, Systemic Lupus Erythematosus, and relapsed/refractory Multiple Myeloma. Timberlyne plans to develop CM313 across a broad range of autoimmune indications. Launched in 2024, Timberlyne has raised $180 million from leading life sciences investors.
Frequently asked questions
Where is Timberlyne therapeutics headquarters?
Timberlyne therapeutics's headquarters is located at San Diego, California, USA, San Diego, California 92134, United States.
How many offices does Timberlyne therapeutics have?
Timberlyne therapeutics operates 1 offices across 1 countries as of 2026.
What is Timberlyne therapeutics's corporate address?
The official corporate address is San Diego, California, USA, San Diego, California 92134.
When was Timberlyne therapeutics founded?
Timberlyne therapeutics was founded in 2024 and has grown to employ approximately 13 people worldwide.
What is Timberlyne therapeutics's phone number?
The main phone number for Timberlyne therapeutics headquarters is —.